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Abstract
The 17-amino-acid N-terminal segment (httNT) that leads into the polyglutamine (polyQ) segment
in the Huntington's disease protein huntingtin (htt) dramatically increases aggregation rates and
changes the aggregation mechanism, compared to a simple polyQ peptide of similar length. With
polyQ segments near or above the pathological repeat length threshold of about 37, aggregation of
htt N-terminal fragments is so rapid that it is difficult to tease out mechanistic details. We describe
here the use of very short polyQ repeat lengths in htt N-terminal fragments to slow this disease-
associated aggregation. Although all of these peptides, in addition to httNT itself, form α-helix-
rich oligomeric intermediates, only peptides with QN of eight or longer mature into amyloid-like
aggregates, doing so by a slow increase in β-structure. Concentration-dependent circular
dichroism and analytical ultracentrifugation suggest that the httNT sequence, with or without added
glutamine residues, exists in solution as an equilibrium between disordered monomer and α-
helical tetramer. Higher order, α-helix rich oligomers appear to be built up via these tetramers.
However, only httNTQN peptides with N=8 or more undergo conversion into polyQ β-sheet
aggregates. These final amyloid-like aggregates not only feature the expected high β-sheet content
but also retain an element of solvent-exposed α-helix. The α-helix-rich oligomeric intermediates
appear to be both on- and off-pathway, with some oligomers serving as the pool from within
which nuclei emerge, while those that fail to undergo amyloid nucleation serve as a reservoir for
release of monomers to support fibril elongation. Based on a regular pattern of multimers observed
in analytical ultracentrifugation, and a concentration dependence of α-helix formation in CD
spectroscopy, it is likely that these oligomers assemble via a four-helix assembly unit. PolyQ
expansion in these peptides appears to enhance the rates of both oligomer formation and
nucleation from within the oligomer population, by structural mechanisms that remain unclear.
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There are 91or 102 different expanded CAG repeat diseases in which a polyglutamine
(polyQ) repeat expansion in a particular disease protein is associated with a
neurodegenerative disorder.1 Intraneuronal polyQ-rich aggregates are found in patient brains
on autopsy, and the polyQ repeat length dependence of aggregation rates in vivo3 and in
vitro4,5 intriguingly mirrors the repeat length dependence of disease risk and age of onset in
the diseases.1 Therefore, it has been of great interest to elucidate the mechanisms by which
polyQ aggregation is initiated.
For simple polyQ sequences, aggregation rates increase with increasing repeat length,5 and
the aggregation reaction follows classical nucleated growth polymerization kinetics.6–9 With
such peptides, while short polyQs in the Q20 range require multimeric critical nuclei for
aggregation initiation and consequently aggregate relatively slowly, polyQ sequences of Q26
or longer exhibit a critical nucleus of ~1, aggregating relatively quickly.6,9 PolyQ
aggregation behavior can be further complicated by the presence of flanking amino acid
sequences such as those found in disease proteins.10–17 Some flanking sequences modestly
affect rates but do not fundamentally change the nucleated growth aggregation
mechanism.9,13,15 Other flanking sequences, however, produce a profound change in
mechanism.15,18–20
In a striking example of a flanking sequence effect, the presence of a short, 17-amino-acid
N-terminal sequence (“httNT”) adjacent to the polyQ at the N-terminus of the protein
huntingtin (htt) leads to an enormous rate acceleration while fundamentally changing the
spontaneous aggregation mechanism.15 In this mechanism, a small portion of monomers
self-associates to form roughly spherical oligomers in which all or part of the httNT segment
is packed into the oligomer core, while the polyQ portion remains disordered and accessible
to antibody binding.15 In a subsequent phase, the rate of aggregation of the remaining
monomers dramatically increases, consistent with the operation of a nucleation event.
Aggregates recovered from the reaction mixture just at the time of this rate increase exhibit
evidence of a remarkable, apparently concerted transformation to more amyloid-like
structure.15 The results are consistent with models in which oligomer formation contributes
to polyQ amyloid formation by providing a scaffold that locally concentrates disordered
polyQ segments.15,21
Many details of this mechanism, however, are yet to be elucidated. Thus, in analogy to
simple polyQ peptides, aggregation rates of httNTQN peptides increase with increasing
polyQ repeat length,4,15 but the mechanism of this repeat length effect on httNTQN
aggregation is not well understood. Furthermore, while recent data suggest that httNT α-
helix formation is part of the oligomer formation process,21 many questions remain,
including the role and timing of α-helix formation, and the role(s) of the α-helical
oligomers, in spontaneous amyloid assembly from httNTQN peptides. Elucidating these
details is difficult with disease-associated polyQ lengths, however, since the nucleation
event that triggers the rapid elongation phase likely occurs stochastically within only a small
percentage of oligomers, leading to runaway elongation that obscures details of the early
assembly mechanism.
We report here the results of a systematic study of httNTQNK2 peptides with short polyQ
repeat lengths designed to slow the early phases of the aggregation reaction. While
aggregation rates are quite slow for all of these peptides, we find some significant
differences in behavior within this repeat length range. For peptides of Q7 or lower, the
aggregation reaction does not progress beyond the α-helical oligomer stage. In contrast,
peptides with Q8 or above are capable of moving on to the amyloid fibril stage, while
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nonetheless retaining an element of α-helix in the amyloid-like aggregates. Analytical
ultracentrifugation (AUC) and circular dichroism (CD) measurements suggest that α-helix-
rich oligomers build up in an organized, hierarchical fashion through tetrameric assemblies
that appear to exist in equilibrium with the monomer under normal solution conditions.
Other data show that oligomer dissociation rates are similar to association rates, suggesting
that monomers can be generated from oligomers to support continued elongation late in the
fibril growth reaction. The data shed light onto how polyQ repeat length contributes to
aggregation rates in these httNTQN peptides and reveal an unprecedented case of a
nucleation event associated with a net decrease in aggregation rate.
Results
Solution properties of httNTQNK2 peptides with a wide range of polyQ repeat length
In order to address several unresolved aspects of the aggregation mechanism of htt
fragments (Introduction), we purified and characterized the solution structures of a series of
httNTQNK2 peptides with N ranging from 3 to 35 (Table 1). Peptides were subjected to a
stringent disaggregation protocol (Materials and Methods) and were immediately subjected
to analytical size-exclusion chromatography (SEC) in phosphate-buffered saline (PBS) at 23
°C. This analysis indicated only one detectible form, the monomer, in each case (Fig. 1a).
One peptide, httNTQ10K2, was further analyzed by AUC. A sedimentation velocity
experiment on this peptide in PBS yielded data that fit well to a predominantly monomeric
solution, with molecular weight (MW)=3500 (calculated MW=3512) (Fig. 1b). However,
low levels of species with MWs of 14,300, 29,100, 45,200, and so forth, were also revealed
in the best fit of the data. A shape change appears to occur upon assembly of the oligomers.
The frictional coefficient decreases from 1.58 for the monomer to 1.24 for the oligomers,
consistent with oligomers being more compact and/or more spherical than isolated
monomers. The AUC results confirm the monomeric nature of the bulk of the sample, while
at the same time suggesting that, under mild conditions, monomers can form low-MW
oligomers whose sizes roughly correspond to 4-mers, 8-mers, 12-mers, and so forth, of the
monomeric httNTQ10K2 peptide. We observe a similar series of small oligomers in the AUC
analysis of httNT itself (data not shown), indicating that polyQ interactions are not required
for formation of tetramers or higher-order oligomeric intermediates. Although we observed
no corresponding oligomeric forms on injection of disaggregated peptides into SEC (Fig.
1a), these apparently fail to appear because they do not chromatograph well.
We obtained independent data consistent with an equilibrium distribution of oligomers in
non-incubated samples of httNT by CD analysis. The α-helical bands in CD spectra of an
httNTQ peptide exhibit a marked concentration dependence consistent with a self-associating
system (Fig. 2a). The high α-helix content of samples analyzed in the 1-mM range is
completely and essentially instantly reversible, since a sample diluted from a high-
concentration solution exhibits a stable CD spectrum identical with that of a freshly made up
solution of the same final concentration (Fig. 2a). This result has several important
implications. First, it suggests that the oligomers observed in the AUC most likely exist in a
rapid dynamic equilibrium with the monomer. Second, it suggests that the oligomers
observed in the AUC almost certainly are α-helix rich. Third, it supports previous data15 in
indicating that the httNT monomer in solution possesses no stable α-helix; rather, the bulk of
the α-helix that is observed in CD analysis, at least at some concentrations, is probably due
to reversible oligomer formation. Our previous CD examination of httNT peptides did not
reveal such a concentration dependence,15 most likely because high concentrations in the 1-
mM range were not analyzed.
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We also determined the CD spectra for each of the httNTQN peptides analyzed in Fig. 1a.
Analysis of these spectra (Materials and Methods) showed only minor differences in
secondary structure between the different httNT peptides, with the exception of a trend of
increasing α-helix with increasing polyQ repeat length (Fig. 2b). Part of this trend may be
due to contributions of α-helix from the polyQ sequence.22 It is also possible that some
additional α-helix forms within the httNT segment in response to polyQ expansion.
Unfortunately, CD spectroscopy is incapable of localizing secondary structure to particular
sequence elements. It is clear that there are no dramatic increases in β-content as polyQ
repeat length increases in this family of monomers, similar to previous results on simple
polyQ peptides,5,23,24 and inconsistent with models positing large amounts of β-structure in
polyQ molecules in solution.25
Aggregation properties of httNTQNK2 peptides with a wide range of polyQ repeat length
We also determined the aggregation kinetics of this set of httNTQN peptides. As reported
previously,15 aggregation rates of a series of httNTQNK2 peptides are strongly dependent on
polyQ repeat length (Fig. 3a). While httNTQ3 (—Δ—) aggregates very slowly, and rates
increase only modestly for httNTQ10K2 (—◯—) and httNTQ15K2 (—◇—), there are
substantial increases in rate as repeat lengths increase further to httNTQ25K2 (—◻—) and
httNTQ35K2 (—▾—). As reported previously,15 polyQ peptides that mimic the htt exon1
fragment by containing both the httNT segment and a Pro10 segment also aggregate very
much faster than simple polyQ of comparable repeat length (httNTQ37P10K2, ☆).
Elongation rates can have an enormous influence on overall aggregation rates.8 We assessed
the ability of each of these monomers to undergo seeded elongation using preformed fibrils
of httNTQ37P10K2 as seeds (Fig. 3a, continuous lines). Although httNTQ3 monomers (▴)
experience very little rate enhancement from seeding, monomers of httNTQ10-K2 (●),
httNTQ15K2 (◆), and httNTQ25K2 (∎) all respond to the presence of seed fibrils. While these
experiments are by no means definitive, the data suggest that, with the exception of httNTQ3,
httNTQN monomers are all capable of undergoing seeded elongation.
For the reactions shown in Fig. 3a, we also analyzed aggregates by Fourier transform
infrared (FTIR) spectroscopy after the reaction appeared to have reached completion. As
previously described for other polyQ peptides containing an httNT flanking sequence,15 we
found that aggregates of httNTQNK2 peptides with N=10 or more Gln residues exhibit three
major bands in the amide I region in second-derivative (Fig. 4a) and primary (Fig. 4b) FTIR
spectra: a band ~1605 cm−1, assigned to the NH2 deformation vibrations of the Gln side
chain;26 a band at 1625–1630 cm−1, assigned to a β-sheet;27 and a band at 1655–1660 cm−1,
assigned to C=O stretching of the Gln side chains26 (Table 2). In contrast, aggregates of the
httNT and httNTQ3 peptides exhibit a single, broad band at 1655 cm−1 (Fig. 4a; Table 2). The
1648–1660 cm−1 amide I region is normally associated with α-helix.27 The β-sheet band is
absent in the httNT and httNTQ3 aggregates.
Other analyses are consistent with the above results. A CD spectrum (Fig. 5a) of partially
aggregated httNTQ3 obtained after 600 h of incubation (red) exhibits an increase in α-helix
content compared with the starting, freshly disaggregated peptide (blue), consistent with the
FTIR data showing dominant α-helix in the isolated oligomeric aggregates. In addition,
electron micrographs (EMs) of httNTQ3 aggregates exhibit clusters of oligomers (Fig. 6a),
while EMs of aggregates of httNTQNK2 peptides with N=10–35 all exhibit fibrillar
morphologies (Fig. 6h–k). Finally, isolated aggregates of the Q10 to Q25 peptides were all
found to be good seeds for the elongation of monomeric httNTQ37P10K2 (Table 3),
consistent with an amyloid-like structure in these aggregates.15,20,28 In contrast, httNTQ3
aggregates not only do not stimulate httNTQ37P10K2 aggregation compared to the unseeded
reaction but also actually appear to inhibit the reaction somewhat (Table 3), similar to
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previously reported29 analogous results with the Aβ40 peptide. Together, these results
suggest that aggregates from Q10 and higher peptides are amyloid-like, while httNTQ3
aggregates have a fundamentally different structure.
Overall, this analysis of a broad range of polyQ repeat lengths suggested that there is a
critical polyQ repeat length, somewhere between Q3 and Q10, at which httNTQNK2 peptides
are able to grow into amyloid-like fibrils. Based on this hypothesis, we carried out a
systematic examination of an additional set of peptides exploring in detail this repeat length
range.
Aggregation of a narrow range of short polyQ repeat lengths in the httNTQNK2 series
We obtained and purified the polyQ repeat length series httNTQ4K2 to httNTQ9K2 and
analyzed their aggregation kinetics (Fig. 3b). After about 800 h of incubation, the httNTQ4K2
(●) and httNTQ5K2 (◯) peptides reach an apparent plateau of ~12% aggregation, while the
httNTQ6K2 (▴) and httNTQ7K2 (◇) peptides reach about 20% aggregation. The httNTQ8K2
(∎) and httNTQ9K2 (Δ) peptides reach substantially higher aggregation levels of 40%
(httNTQ8K2) and 50% (httNTQ9K2) by 800 h.
The structures of the aggregated products of these peptides exhibit a polyQ repeat length
dependence that roughly correlates with the different aggregation kinetics. Second-
derivative (Fig. 4c) and primary (Fig. 4d) FTIR spectra in the amide I region show a
dominant α-helix band (Table 2) for the late-stage aggregates of the Q4, Q5, Q6, and Q7
peptides, in analogy to the aggregates of httNT and httNTQ3. In contrast, aggregates of the Q8
and Q9 peptides isolated at 800 h exhibit spectra essentially identical with those of all polyQ
amyloid fibrils, featuring strong Gln side-chain bands and a strong β-structure band (Fig. 4c
and d; Table 2). In the EM, the Q4, Q5, Q6, and Q7 (Fig. 6b–e) peptides exhibit only non-
fibrillar aggregates. Although EMs of the Q8 and Q9 peptide aggregates (Fig. 6f and g) do
not exhibit clear fibrillar morphologies, there is a suggestion of a filamentous substructure
that may be obscured due to the greater relative mass from the non-amyloid (see below)
httNT component in these peptides. A non-amyloid structure for the httNTQ7K2 aggregates is
also indicated by the negligible thioflavin T (ThT) fluorescent signal from these aggregates
(Fig. 7c, red curve), compared to a typical amyloid-like response from aggregates of
httNTQ9K2 (Fig. 7c, blue curve). In addition, httNTQ7K2 solutions grow in α-helix content
by CD over the aggregation reaction time course (Fig. 5b), and dynamic light scattering
(DLS) data (Fig. 7a and b) yield a narrow range of relatively small, oligomersized particles
throughout this time course.
Overall, these data suggest that httNTQNK2 peptides with polyQ segments of seven or less
grow into aggregates that are incapable of nucleating a β-rich amyloid structure and
therefore accumulate as stable, α-helix-rich, ThT-negative aggregates. If the polyQ segment
is of Q8 or longer, however, β-rich aggregates slowly develop, with overall aggregation
levels increasing as polyQ repeat lengths increase.
Time course of httNTQ8K2 aggregation
The above data define a sharp repeat length threshold in httNTQN peptides for their ability to
convert from α-rich oligomers to β-rich fibrils. While suggestive, these data do not formally
address whether or not those peptides that develop into β-rich aggregates do so via an α-rich
oligomeric intermediate. To address this question, we isolated httNTQ8K2 aggregates at
different reaction times to spectroscopically examine their secondary structures. We found
that aggregates isolated at 75 h exhibit a very strong α-helix band in the FTIR at 1653 cm−1
(Fig. 8a). In addition, the fluorescence emission maximum for Trp17 in the isolated
aggregates occurs at 353.5 nm (Fig. 3b, ◻), identical with that for the monomeric peptide
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and consistent with a Trp residue that is highly solvent exposed.15 Aggregates isolated at
243 h exhibit not only a complex FTIR spectrum with shoulders at positions of the dominant
bands of mature httNTQN amyloid fibrils (Fig. 8a) but also a shift in Trp fluorescence
consistent with partial burial in solvent-excluded structure (Fig. 3b). By 338 h, the growth of
β-structure in the FTIR (Fig. 8a) and the shift in Trp fluorescence (Fig. 3b) are nearly
complete. By 675 h, the FTIR spectrum of the httNTQ8K2 aggregates (Fig. 8a) is identical
with spectra of httNTQN amyloid fibrils (Fig. 4b), and the Trp fluorescence has reached a
plateau at 348 nm (Fig. 3b). These data support a model in which α-helix-rich oligomers
serve as intermediates in the formation of httNTQN amyloid Interestingly, the FTIR spectra
(Fig. 8a) also show that the N–H bending resonance at ~1605 cm−1 that is a common feature
of all polyQ amyloid aggregates is negligible or not present in the α-helix-rich httNTQ8K2
oligomeric intermediate but develops over time, in parallel with β-sheet (in contrast to a
recent description of ataxin-3 aggregation30). This suggests that this relatively sharp band is
specifically associated with conformationally restricted, presumably H-bonded Gln side
chains.31 This interpretation in turn supports previous data suggesting that the polyQ
segments are disordered in the httNTQN oligomeric intermediates.15
The inability of polyQ httNTQN molecules with N<8 to aggregate to completion suggests
that oligomer formation is reversible and is controlled by a characteristic critical
concentration or Keq. To test this hypothesis, we monitored the ability of isolated httNTQ8K2
oligomers to dissociate (Materials and Methods). The results (Fig. 3c) show that oligomers
in PBS at 37 °C dissociate within 20 h to an equilibrium concentration, confirming their
relatively low stability and relatively rapid dissociation kinetics, on a par with their
association kinetics (Fig. 3b).
Hydrogen–deuterium exchange FTIR on final aggregates
Recent solid-state NMR experiments show that the httNT segment of httNTQ30P6K2 amyloid
fibrils contains a well-formed α-helical segment in residues 4–11.21 Given the strong
secondary structural features observed in the FTIR spectra of the oligomeric intermediates
and amyloid final products described above, one might have expected to observe an FTIR
confirmation of this residual α-helical component. Unfortunately, the C=O stretch band
from the Gln side chains in the final amyloid product directly overlaps the α-helix position
(Table 2).
We used isotope-edited FTIR spectroscopy32 to investigate the possible existence of α-helix
in the final fibril product. Figure 8b shows a typical FTIR spectrum in the amide I and II
regions for an amyloid-like aggregate of a simple polyQ peptide (K2Q37K2) grown and
examined in H2O (designated the “H–H” form in Fig. 8b). This spectrum exhibits the three
bands for the Gln side chain and the β-sheet amide groups characteristic of all β-rich polyQ
aggregates (Table 2). The assignment of these bands to the Gln side chains (1605 and 1655–
1660 cm−1) and to the β-sheet (1625–1630 cm−1) was based on literature reports.26,27,30
None of these bands changes position or significant intensity when this aggregate is
transferred to D2O (Fig. 8b, H–D), suggesting that the protons associated with all three of
these amide resonances are strongly protected from hydrogen–deuterium exchange.
When K2Q37K2 is aggregated and analyzed in D2O, the above three bands disappear and are
replaced by two new ones (Fig. 8b, D–D). [These new band locations were assigned to the
β-sheet (~1612 cm−1) and to the C=O stretch from the Gln side chain (~1638 cm−1) as
follows. It was previously reported that deuteration of Gln analogs has the effect of moving
the C=O stretch band from around 1672 cm−1 26 to about 1640 cm−1.33 Furthermore,
deuteration, as expected,32 has been observed to shift the Gln side-chain N–H band
completely out of the amide I region in a Gln-containing lipopeptide.34 The amide II band at
1535 cm−1 is also expected to disappear; deuteration of proteins typically shifts the amide II
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bands from ~1550 cm−1 to ~1450 cm−1 .35] Reanalyzing this deuterated K2Q37K2 aggregate
in H2O (Fig. 8b, D–H) produces no change, once again indicating that these FTIR bands are
associated with amides that are strongly resistant to hydrogen–deuterium exchange.
A similar series of spectra of httNTQ15K2 final aggregates exhibit some subtle but important
differences. The spectrum of httNTQ15K2 aggregates grown and analyzed in H2O (H–H) is
remarkably similar to the corresponding H–H spectrum for K2Q37K2 (Fig. 8b). Furthermore,
when httNTQ15K2 is grown in D2O and analyzed in D2O, its D–D FTIR spectrum is also
essentially identical with the corresponding D–D K2Q37K2 spectrum (Fig. 8b). However,
when httNTQ15K2 aggregates grown in D2O are transferred into H2O, this D–H spectrum is
altered to produce two additional resonances, a band in the amide II region centered at 1545
cm−1 and a shoulder in the amide I region at ~1655 cm−1 (Fig. 8b, arrow). The emergence of
these bands suggests that httNTQ15K2 aggregates possess an exchangeable, non-β-element of
regular secondary structure that is not present in K2Q37K2 aggregates. Interestingly, the
secondary structural feature associated with both of these band positions is the α-helix.27
The simplest explanation for this newly observed structural element is that it belongs to the
httNT portion of the httNTQ15K2 peptide. This suggestion that elements of the httNT
sequence reside in flexible, solvent-accessible α-helix in the amyloid fibril is consistent with
recent solid-state NMR results showing the same thing.21
Discussion
Our model for the nucleation mechanism for amyloid formation by httNTQN-type peptides
suggested by these and previous experiments is shown in Fig. 9. In httNTQN monomers in
solution (Fig. 9a), the polyQ portion (orange) exists in a compact coil state36–39 with no
stable, regular secondary structure.5,6,23,24 The httNT segment (green) in isolation is also
disordered but compact, with a modest tendency toward α-helix formation15 that is greatly
enhanced in certain environments and solvents.15,40,41 Based on data presented here, it
appears that the httNT segment becomes engaged in stable α-helix immediately upon
assembly into oligomers and retains at least a portion of this α-helical character throughout
the nucleation and elongation processes (Fig. 8a) as well as in the final httNTQN amyloid
fibrils (Fig. 8b).21 Based on the high α-helix content of the oligomeric intermediates (Figs. 5
and 8), the tetrameric building block suggested by the AUC experiment (Fig. 1b), the
concentration dependence of α-helix formation in a freshly solubilized httNT peptide, and
the helical packing of httNT domains in crystals of some htt N-terminal fragment
derivatives,41 we believe that some sort of packed four-helix assembly unit (Fig. 9c)
mediates oligomer assembly.
The ability of the httNT segment to mediate a regular tetramerization of htt N-terminal
fragments has not been previously recognized and may have significant implications for the
cellular life of this poorly understood protein. Low MW oligomers of htt have been observed
in several cell biology studies.42 Whether these multimers reflect the operation of a
generalized, reversible α-helix rich oligomer formation, or are associated with specific,
perhaps pathological, processes, remains to be determined.
The timing of the structural consolidation that occurs within the aggregate pool in these and
previous15 studies is consistent with nucleation occurring as a structural rearrangement
within the oligomer fraction (Fig. 9g). At the same time, the poor stability of oligomers
relative to fibrils (Fig. 3b), as well as the ability of oligomers to relatively rapidly dissociate
(Fig. 3c), suggests that most oligomers that have not undergone this rearrangement/
nucleation event ultimately serve as a reservoir for releasing monomers (Fig. 9b) to support
continued fibril elongation (Fig. 9i). Given that nucleation of amyloid formation for at least
some polyQ repeat lengths tends to occur at a point where the reaction mixture is still ~80%
Jayaraman et al. Page 7













monomeric15 (Fig. 3b), it is likely that the bulk of the final amyloid mass (Fig. 9j) is formed
via elongation by monomer addition of a relatively small number of oligomer-derived nuclei
and fibrils (Fig. 9h and i). The pivotally important role in the aggregation mechanism of the
httNT segment and its ability to engage in α-helix-rich oligomer structure are further
supported by experiments characterizing the abilities of httNT analogs to inhibit the
oligomer-dependent aggregation pathway.43
Figure 9 shows nucleation occurring within a 12-mer, but this schematic is not meant to
suggest that sporadic nucleation events are confined to a particular oligomeric species. In
fact, in the short polyQ htt N-terminal fragments studied here, the aggregation kinetics
suggest that significant nucleated growth of amyloid does not begin until after 200 h of
incubation, at a time when about 20% of the sample consists of pelletable (i.e., much larger
than 12-mer) α-helix-rich oligomers (Fig. 3b). On the other hand, it is likely that nucleation
occurs within much smaller oligomers in peptides such as httNTQ35K2, where amyloid
formation occurs rapidly with little, if any, apparent lag time15 (Fig. 3a).
There is an important distinction to be made between how amyloid structure is proposed to
be nucleated in the model summarized in Fig. 9 and classical nucleation theory. In the
classical theory, the nucleus, its oligomeric precursors, and its polymeric products, are all
formed via a continuous series of discrete homologous equilibria.44 In contrast, the Fig. 9
model consists of a series of abrupt, differentiated steps: (a) tetramer formation from
monomers, (b) packing of tetramers into higher oligomers, (c) nucleation within individual
oligomers, and (d) elongation of nuclei into amyloid fibrils by monomer addition. Both the
classical mechanism and the oligomer-mediated nucleation mechanism, however, share the
central feature of a critical, energetically unfavorable step that must be traversed before
strongly thermodynamically favored amyloid formation reaction can proceed. It is important
to stress that the α-helix-rich oligomers are themselves not nuclei for amyloid growth. Thus,
contrary to expected behavior of nuclei, α-helical oligomers (a) exhibit a finite stability
allowing characterization by AUC, CD, FTIR, DLS, EM, and sedimentation; (b) do not
structurally resemble the final amyloid product; and (c) are incapable of “seeding” amyloid
growth.15 Instead, the nucleus is an ephemeral species (formed within the oligomer fraction)
that is uniquely capable of initiating the propagation of amyloid structure. As previously
pointed out,15 the model shown in Fig. 9 is similar in some respects to the “nucleated
conformational conversion” model45 for initiation of yeast prion aggregation under certain
conditions. Only further studies will determine whether such models will ultimately be
adequate to describe other amyloid formation reactions that feature oligomeric
intermediates.
Are the α-helical oligomers on- or off-pathway?
The role of non-amyloid oligomers in the amyloid assembly process has been much
debated,46 with claims that oligomers are either obligate intermediates for fibril formation
(on-pathway)45,47 or not required for fibril formation (off-pathway).48 The concept of
intermediates being on- or off-pathway derives from the protein folding field, where the
issue is whether observed intermediates are obligatory stages through which all protein
molecules must pass during productive assembly, or whether their formation merely
represents a shunt that must ultimately be reversed before their molecules can productively
fold. Indeed, it can be very difficult to kinetically distinguish on-pathway folding
intermediates from off-pathway, since both can be seen to build up and decay during the
folding reaction.49,50
In analogy, in many amyloid formation reactions, including those of the htt N-terminal
fragments described here, non-amyloid aggregates are formed early but are no longer
evident by the end of the reaction. In the model shown in Fig. 9, the fate of some of the
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initial α-helical oligomers is to undergo a nucleation process to initiate amyloid growth. At
the same time, a significant portion of oligomers probably do not undergo nucleation and
persist only until depletion of the monomer pool, by fibril elongation, creates a
thermodynamic driving force for their dissociation to monomers. This dynamic is suggested
by the very slow buildup of β-structure in a persistent field of α-helical oligomers (Figs. 3b
and 8) coupled with the relatively rapid dissociation of α-oligomers back to monomers
(Figs. 2a and 3c). While those oligomers that play a role in nucleation are clearly on-
pathway for amyloid fibril formation, the oligomers that serve only as a reservoir for
monomers can be considered off-pathway, in strict analogy to the protein folding
experience.51 Thus, at least for htt N-terminal fragment amyloid formation, the α-helix-rich
oligomeric intermediates serve both on-pathway and off-pathway roles. It would be
premature to extend these observations to all oligomeric intermediates in amyloid formation
reactions, however. Many such oligomers appear to possess significant levels of β-structure,
and both their roles in nucleation and their abilities to dissociate have been little
investigated.
This dual role for oligomers should have different consequences in vitro and in vivo. In
vitro, as monomers are depleted during elongation, those oligomers that have not undergone
amyloid nucleation should tend to dissociate and disappear according to their characteristic
critical concentrations. In cells continuously producing new monomers, however, this
mechanism will essentially lead to a steady-state concentration of oligomers, as has been
observed.42,52
Structures and role in amyloid nucleation of α-helical oligomeric intermediates
Several models exist in the literature for how httNT and polyQ might interact to provide the
rapid polyQ amyloid formation kinetics observed in such molecules. Based on domain
accessibility measurements of isolated oligomeric intermediates, we proposed that httNT is
buried, and polyQ is disordered and solvent exposed, in oligomers, leading to a model
conceptually like that shown in Fig. 9.15 A similar oligomer-mediated model was also
proposed by Tam et al.,16 based primarily on photocross-linking data; this group also
proposed the existence of non-covalent, long-range httNT–polyQ interactions that might
enhance nucleation of amyloid growth by favoring particular polyQ conformations. Quite
different models for oligomer formation and structure, in which the oligomers are held
together primarily by intermolecular polyQ interactions, have been proposed based on
simulations53 or experimental data.54 We think that our observation that the httNT segment
alone forms oligomeric species whether or not it is connected to a polyQ chain, and that
httNT by itself exhibits a concentration dependence in forming α-helix in CD measurements,
argues for httNT playing a leading (rather than a following) role in oligomerization. At the
same time, it remains possible that intermolecular polyQ association might play a supporting
role in helping to stabilize oligomers initially brought together by httNT interactions. This
hypothesis remains to be tested experimentally.
Because of this structural role, α-helix-rich oligomers also play an important functional role
in greatly stimulating overall amyloid formation rates. This is illustrated by a comparison of
the aggregation kinetics of molecules containing a Q25 repeat. While a 5-μM solution of
httNTQ25K2 requires only ~20 h to reach 50% amyloid formation (Fig. 3a), under the same
conditions, a 10-times higher concentration of K2Q25K2 reaches 50% amyloid formation
only after a 10-times longer incubation time (~250 h).9 The prime importance of httNT self-
association in driving amyloid formation kinetics in this system is also supported by our
observations, reported elsewhere,43 of strong aggregation inhibition by httNT and various
derivatives. One interesting outcome of the httNT-mediated nucleation mechanism is that the
observed rate of spontaneous amyloid formation is driven by a portion of the peptide
sequence that never actually engages amyloid structure.
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This pivotal role of an α-helix-rich oligomeric intermediate in amyloid nucleation may not
be unique to the htt system. Similar mechanisms have been suggested for other amyloid
systems,55 including α-synuclein,56 amyloid β,57 islet amyloid polypeptide,58 and several
model systems.59,60 The htt system, however, appears to be unique in that a substantial
portion of the α-helix that is the basis of oligomer formation is actually retained in the final
fibrils21 (Fig. 8b). The unusual retention of α-helix in httNT may be partly due to its intrinsic
α-helical propensity, to a constitutive inability of elements of the httNT sequence to form
amyloid,61 or to a fastidious discrimination by the polyQ segment against incorporating
substantial portions of non-Gln sequence into the growing amyloid core. The clean
compartmentalization of the htt mechanism, which can be teased apart by damping down
aggregation kinetics through adjustments in polyQ repeat length, has allowed us to elucidate
critical aspects of this general mechanism.
Mechanistic source of expanded polyQ acceleration of httNTQN aggregation
Previously, we observed that expanded polyQ sequences in httNTQN peptides tended to
increase the efficiency with which these peptides form oligomers.15 We suggested that this
trend might play a role in polyQ expansion enhancement of amyloid formation rates. We
also provided FRET data consistent with the induction of a conformational expansion within
the httNT segment by polyQ repeat expansion that could be the source of increased oligomer
formation.15 Predictions from simulations, while differing considerably in detail, tend to
support this conformational effect.53,62,63
At the same time, we believe that further studies are required to elucidate the basis of the
polyQ expansion effect on oligomer formation. Data presented here indicate that polyQ
expansion also contributes to the rate of amyloid formation coming out of the α-helix
oligomer pool. Thus, amyloid nucleation in httNTQN peptides does not occur, even at long
incubation times, unless the polyQ repeat length is at least Q8 (Figs. 3b and 4c).
Furthermore, while oligomers of httNTQ8K2 populated by 100 h require another 300 h
before the isolated aggregates are completely amyloid-like (Fig. 3b), fibril formation (via
oligomers) from httNTQ35K2 monomers is complete after only a few hours under the same
conditions (Fig. 3a). This great rate enhancement of the monomer-to-fibril transformation
cannot be explained by rate effects on oligomer formation alone and must consider the
nucleation and elongation events. PolyQ repeat length dependent secondary nucleation
effects44,64–66 might contribute to the repeat length dependence of overall aggregation rates,
but there is no indication that polyQ amyloid formation is susceptible to this process under
typical growth conditions.6–9 In combination with other methodologies, reducing polyQ
repeat length in order to slow aggregation rates may lead to future improvements in our
understanding of the polyQ repeat length effect.
Amyloid formation by very short polyQ sequences
Our finding that httNTQN peptides as short as Q8 are capable of making amyloid is
consistent with X-ray diffraction67 and mutational68 analyses, suggesting β-sheet widths of
~7 amino acids in simple polyQ amyloids. β-Sheet widths in the httNTQ8K2 peptide may be
as much as 9 or 10 residues, since ssNMR of fibrils of a longer polyQ htt N-terminal
fragment showed that Ser16 and Phe17 also exist in β-sheet.21 A recent analysis of the
repeat length dependence of short polyQ solution conformations suggests that simple polyQ
peptides in the Q8–Q12 repeat length range should not be capable of making amyloid.39 As
shown herein, however, the biophysics appears to change significantly with the addition of
flanking sequences that can, for example, contribute at least a few residues to the β-sheet21
and hence to its energetics.
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The driving force for nucleated growth
Although nucleation events are normally associated with enhanced aggregation kinetics, the
defining feature of nucleation is more accurately characterized as the overcoming of a
significant kinetic barrier to a thermodynamically favorable transformation. This subtle
distinction is illustrated in Fig. 3b, where it can be seen that the nucleation and elongation
phases of amyloid formation by the httNTQ8K2 and httNTQ9K2 peptides exhibit kinetics that
are actually slower than the preceding rates of oligomer formation (indicated by the broken
line extrapolation). Nucleated growth of amyloid by these peptides occurs in spite of the




Water (HPLC grade), acetonitrile (99.8% HPLC grade), hexafluoro-2-propanol (99.5%,
spectrophotometric grade), and formic acid were from Acros Organics; trifluoroacetic acid
(TFA) (99.5%, Sequanal Grade) was from Pierce; and ThT was from Sigma. Chemically
synthesized peptides (Table 1) were obtained from either the Keck Biotechnology Center at
Yale University† or GenScript, Inc. In general, peptides were purified and subjected to
rigorous disaggregation in volatile solvents (hexafluoro-2-propanol/TFA) for 16 h, followed
by evaporation of solvents, resuspending the peptide film in TFA–water (pH 3) solution and
ultracentrifugation at 435,680g, as previously described.9,15,69 Peptides were used
immediately, without storage, after disaggregation. Most peptides contained a conservative
Phe→Trp replacement at position 17 (Table 1) previously shown to have little effect on
aggregation rates.15 For FTIR and ThT binding characterization and for use in seeding
kinetics, aggregates were isolated from ongoing reactions and resuspended, and aggregate
concentrations were determined as previously described.69
Determination of concentrations
Determination of monomer and aggregate concentrations is critical to obtaining interpretable
data. We used analytical HPLC with integration of the peak from an A215 trace to quantify
peptides. Although the A215 absorption is largely determined by the peptide bond, different
sequences can exhibit significantly different extinction coefficients because of side-chain
contributions. We calculated the expected extinction coefficient in the HPLC solvent for
each sequence using a modification of the method of Kuipers and Gruppen.70 After HPLC
purification of each peptide, the A215 absorbance of a portion of the pool was determined,
and the concentration of the peptide was calculated from the extinction coefficient
calculated from the Kuipers and Gruppen values.70 Calibrated peptide solutions were then
adjusted in concentration for use as an HPLC standard, and a standard curve of peak area
with respect to injected mass was generated for each peptide, allowing future determinations
of mass for each peptide. These modifications of the published70 procedure compensate for
observed sequence-dependent recovery efficiencies in analytical reverse-phase HPLC.
Secondary structure of the monomeric httNT peptides by CD spectroscopy
Far-UV CD measurements were performed on a JASCO J-810 spectropolarimeter using 0.1-
cm- and 0.1-mm-path length-cuvettes. For the concentration dependence of httNTQ (Fig. 2a),
lyophilized purified peptides were dissolved in pH 3 (TFA) water and centrifuged at
435,680g for 2 h; the top 50% of the supernatant was removed, adjusted to 10 mM Tris–
HCl, pH 7.4, and diluted with the same buffer to the desired concentrations. Spectra were
†http://keck.med.yale.edu/ssps/
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collected at 1-nm resolution at a scan rate of 100 nm min−1. Four spectra were collected and
averaged for each sample and corrected for the buffer blank. For measuring the
conformations of monomeric httNTQN peptides (Fig. 2b), peptides were disaggregated as
described in Materials, and centrifugation supernatants were adjusted to 10 mM Tris buffer,
pH 7.4, and then filtered through 20-nm filters (Anotop inorganic membrane disc filter,
Whatman) and immediately subjected to CD measurements. For aggregation reactions (Fig.
5), samples were prepared in PBS, pH 7.4, and filtered through the 20-nm filter, and then
400-μl aliquots of the ongoing reaction were subjected to CD measurements at 37 °C.
Spectra were recorded from 195 to 260 nm at 1-nm resolution with a scan rate of 50 nm
min−1. Six scans were averaged and the buffer spectrum was subtracted. For Fig. 2b, CD
spectra were analyzed using the CONTINLL program from the CDPro package
(lamar.colostate.edu/~sreeram/CDPro) in which the SP37A reference set (ibasis 5) was used
to estimate the amount of secondary structure.71
Size-exclusion chromatography
To assess the aggregation state of peptides prior to spectroscopic analysis, we used a
Superdex peptide column with a MW range of 7000 (GE Health Sciences) equilibrated in
PBS on an Agilent 1200 isocratic HPLC system with a flow rate of 0.4 ml min−1. Freshly
disaggregated peptide samples in TFA–water, pH 3.0, were adjusted to PBS, pH 7.4, using
10× PBS. Samples (100 μl of ~10–15 μM) were immediately injected with elution
monitored at 214 nm.
Analytical ultracentrifugation
Sample preparation was tailored to insure a rigorous match to the buffer reference. Thus,
freshly disaggre-gated httNTQ10K2 in pH 3 TFA–water was transported on ice to the AUC
laboratory (30 min). The sample was then adjusted to PBS buffer using a 10× PBS stock and
dialyzed for 2 h against PBS buffer at 23 °C. The dialysate was centrifuged 20–30 min in a
refrigerated Eppendorf centrifuge (4 °C) to clear any pelletable aggregates. The recovered
supernatant was used in the analytical centrifuge run, which was started approximately 30
min after the end of the centrifugation time. A reference buffer sample was prepared by
following the above procedure, but with no peptide present, using a common dialysis buffer.
Sedimentation velocity experiments in a Beckman Optima XL-I analytical ultracentrifuge
were used to evaluate the distribution of species in the peptide preparations. Epon double-
sector centerpieces were filled with 400 μl of samples. For all experiments, the reference
buffer sample was loaded into the reference sector. Samples were centrifuged at a rotor
speed of 50,000 rpm, and data were collected in fringes using interference optics.
Sedimentation velocity analyses were performed with the program SEDFIT‡ (as described
in detail in Ref. 72) that carry out size distribution analyses based on Lamm equation
modeling.73–75 Briefly, the analysis of velocity profiles was performed by direct boundary
modeling by distributions of Lamm equation solutions c(s)
(1)
with where a(r,t) denotes the measured absorbance or interference profiles at position r at
time t, b(r) and b(t) are the characteristic systematic offsets,73 and χ1(s,F,r,t) are solutions of
the Lamm equation
‡Available online at http://www.AnalyticalUltracentrifugation.com
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(with w denoting the rotor angular velocity, D the diffusion coefficient, and s the
sedimentation coefficient) at unit loading concentration.76D and s are related via the
frictional ratio F=(f/f0) and the hydrodynamic scale relationship
(3)
(with h and r denoting the solvent viscosity and density, respectively, and  the partial
specific volume of the macromolecules, calculated using the software SEDNTERP73). The
partial specific volume for the htt peptides differs from that of globular proteins due to its
unusual amino acid sequence composition and was determined to be 0.655 ml g−1. Initial fits
to the data on httNTQ10K2 with a variety of values for  in the calculated range and a single
F value gave incompatible results, either with monomer MWs at expected values and
oligomer MWs that were too large or monomer MWs that were unexpectedly low in fits
with oligomer MWs that were expected. From these data fits, it was clear that F was
different comparing the monomer and multimer. For this reason, a fit to a model that allows
for a variable F value for monomer versus oligomers was employed (i.e., a model that
assumes a conformational change in assembly of oligomers from monomers), taking
advantage of the known MW of the monomer as the basis for assembly of the oligomers in
the fitting. Satisfactory fits to the data were generated with this approach, yielding an F
value of 1.58 for the monomer and an F value of 1.24 for the oligomers.
Aggregation and seeded elongation kinetics
Htt peptides were tested for their aggregation propensity and cross-seeding ability using an
analytical HPLC sedimentation assay.69 Disaggregated httNTQN peptides were incubated in
PBSA (PBS plus 0.05% sodium azide, w/v) at 37 °C, aliquots were periodically removed
and centrifuged, and the supernatants were analyzed by analytical HPLC.
For seeded elongation kinetics, disaggregated peptides were incubated at 37 °C in PBS
either alone or in the presence of the 7.5% freshly grown aggregates delivered from the
stock suspension described in Materials. The rate of monomer loss over incubation period
was calculated and compared with the spontaneous aggregation rate in order to estimate the
seeding efficiency.
For the oligomer stability experiment, 445 μl of 620 μM freshly disaggregated httNTQ8K2 in
PBSA was incubated at 37 °C for 120 h. A 300-μl aliquot was removed and centrifuged at
14,000 rpm in a tabletop centrifuge. The supernatant was carefully removed, and the pellet
was suspended in 200 μl of PBSA with gentle vortexing. A 5-μl aliquot of the resulting
suspension was removed and added to 30 μl of formic acid and incubated for 30 min and
then analyzed by analytical HPLC to determine the total peptide concentration (monomer
plus aggregates) in the sample. For the dissociation kinetics, 25-μl aliquots were removed
and centrifuged 30 min at 14,000 rpm, and 5 μl of each supernatant was added to 30 μl of
formic acid, and the amount of peptide in the sample was determined by analytical HPLC to
yield the monomer concentration at each time point.
ThT fluorescence
Aggregates were isolated as described above and resuspended in 350 μl of PBS, to which a
ThT stock solution was added to give a final ThT concentration of 40 μM. Fluorescence
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emission spectra were collected using a Fluorolog-3 Research Spectrofluorometer (Horiba
Jobin-Yvon). Samples were excited at 445 nm and emission spectra were recorded from 460
to 600 nm. Excitation and emission slits were at 2 nm and 5 nm, respectively.
Tryptophan fluorescence measurements
Tryptophan fluorescence measurements on aggregates were conducted as previously
described, using isolated aggregates resuspended in PBS.15
DLS measurements
DLS measurements were carried out on a Wyatt DynaPro light-scattering instrument.
Approximately 80-μl aliquots of ongoing aggregation reactions were transferred to wells of
a 386-well plate and the autocorrelation functions were measured. The correlation curves
were deconvoluted using Dynamics V6 software (Wyatt Technologies Corp.) to obtain size
distribution and hydrodynamic radii (Rh).
Transmission electron microscopy
Aliquots of aggregation reaction of various htt peptide samples were placed on freshly glow-
discharged carbon-coated grids (Electron Microscopy Sciences, Hatfield, PA) and incubated
for 1 min, and the excess sample was wicked away with filter paper. The sample grid was
then washed with deionized water, stained with 1% uranyl acetate (w/v) solution for 3 s, and
blotted. Grids were imaged using Tecnai T12 microscope (FEI Co., Hillsboro, OR)
operating at 120 kV and 30,000×magnification and equipped with an ultrascan 1000 CCD
camera (Gatan, Pleasanton, CA) with post-column magnification of 1.4×. Aggregates
visualized by this protocol almost certainly are present in the sampled solutions and are not
induced artifacts; previously, we showed that a solution of an htt N-terminal fragment
monomer solution, added to a grid and stained by the above procedure, is free of aggregates
and identical in appearance to an empty mock-stained grid.15
FTIR spectroscopy
To provide sufficient aggregates for analysis, we conducted reactions with monomers in the
0.5–1 mM range. This did not appreciably alter aggregation rates, however, presumably
because of the low concentration dependence of the formation of these non-amyloid
intermediates.15 Aggregates were harvested by centrifugation at 14,000 rpm for 45 min on a
bench top centrifuge, and the pellets were washed three times with PBS to remove traces of
TFA and the other solutes. Pellets containing aggregates were then resuspended in 4 μl of
PBS at around 10 mg ml−1 concentration, and spectra were acquired by placing the
aggregate suspension between two polished CaF2 windows using a BioCell module
(BioTools, Inc.) on an ABB Bomem FTIR instrument. Data from a total of 400 scans were
collected with 4 cm−1 resolution at room temperature and averaged for each sample.
Residual buffer absorption was subtracted and spectral components were identified from
second-derivative minima using PROTA software.
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Molecular size distribution of httNTQN peptides in PBS, pH 7.5. (a) Analytical SEC (at 23
°C) of peptides. (b) Sedimentation velocity analysis of 50 μM httNTQ10K2 at 20 °C. Data
were analyzed using a continuous c(s) distribution model implemented in the program
SEDFIT. The frictional ratio for each sample was a fitted parameter in the analysis, yielding
1.58 for the monomer and 1.24 for the oligomeric species. Sedimentation data, with global
fits, are shown for httNTQ10K2 in the top frame, and resulting residuals for the analysis are
given below the experimental data in the middle frame. The c(s) profile for the peptide
species is shown in the bottom frame.
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CD analysis of monomeric httNTQN peptides in Tris–TFA, pH 7.4. (a) Concentration
dependence of the CD spectra of httNTQ: green, 1.3 mM; blue, 0.67 mM; orange, 0.33 mM;
black, 0.15 mM; red, 0.10 mM obtained by dilution from a 0.76-mM solution. All samples
were analyzed in a 0.1-mm-path-length cell, except for the 0.10- mM sample, which was
analyzed in a 0.1- cm cell. (b) Secondary-structure contents calculated (Materials and
Methods) from CD curves, obtained in a 0.1- cm-path-length cell, of the following samples:
httNTQ3, 36 μM (brown); httNTQ10K2, 32 μM (green); httNTQ15K2, 28 μM (yellow);
httNTQ25K2, 25 μM (red); httNTQ35K2, 27 μM (black); httNTQ37-P10K2 20 μM (orange).
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Aggregation kinetics of httNTQN peptides in PBS at 37 °C. (a) ~5 μM monomer with
(continuous lines) and without (broken lines) 7.5 wt% httNTQ37P10K2 aggregate seeds:
httNTQ3 (Δ,▲), httNTQ10K2 (◯,●), httNTQ15K2 (◊,◆), httNTQ25K2 (□,■), httNTQ35K2
(▼), and httNTQ37P10K2 (☆,★). The figure was modified from Ref.15. (b) Monomer loss
(continuous lines) and shift in the Trp fluorescence emission maximum of isolated
aggregates (curved broken line) for incubation of ~5 μM httNTQ4K2 (●), httNTQ5K2 (◯),
httNTQ6K2 (▲), httNTQ7K2 (◊), httNTQ8K2 (■,□), and httNTQ9K2 (Δ); the straight broken
line is an extrapolation of the initial oligomer formation kinetics for httNTQ9K2. (c)
Dissociation kinetics of httNTQ8K2 oligomers collected after 120 h of incubation. The
broken line represents total peptide (aggregate plus monomer) in the incubated sample.
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FTIR spectra of isolated final aggregates. Second-derivative (a) and primary (b) spectra of
final aggregates of httNT (2160 h), httNTQ3 (2160 h), httNT Q10K2 (1540 h), httNTQ15K
(1080 h), httNTQ25K2 (80 h), httNTQ35K2 (24 h), and httNTQ37P10K2 (24 h). Second-
derivative (c) and primary (d) spectra of final aggregates of httNTQ4K2 (1020 h), httNTQ5K2
(1140 h), httNTQ6K2 (960 h), httNTQ7K2 (1040 h), httNTQ8K2 (950 h), and httNTQ9K2 (950
h).
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CD analysis of httNTQN aggregation. CD curves of peptides incubated in PBS at 37 °C. (a)
74 μM httNTQ3 for 0 h (blue) and 600 h (red). (b) 32.6 μM httNTQ7K2 for 0 h (blue), 48 h
(green), and 120 h (red). Note that spectra reflect the mixture of monomers and aggregates at
each time point.
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Negative stained EMs of httNTQN peptide aggregates: httNTQ3 (a, 2160 h), httNTQ4K2 (b,
912 h), httNTQ5K2 (c, 1210 h), httNTQ6K2 (d, 800 h), httNTQ7K2 (e, 820h), httNTQ8K2 (f,
840 h), httNTQ9K2 (g, 860 h), httNT Q10K2 (h, 800 h), httNTQ15K2 (i, 1080 h), httNTQ25K2
(j, 82 h), httNTQ35K2 (k, 24 h), and httNTQ37P10K2 (l, 20 h). The scale bar represents 50 nm.
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Analysis of httNTQNK2 aggregation. Autocorrelation functions (a) and particle size
distributions (b) obtained from DLS measurements of 32.6 μM httNTQ7K2 incubated in PBS
at 37 °C for the times indicated. (c) Fluorescence emission spectra of ThT alone (black) or
bound to final aggregates of httNTQ7K2 (red) or httNTQ9K2 (blue) at monomer-equivalent
concentrations of 30 μM.
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FTIR structural and mechanistic analysis. (a) Primary FTIR spectra of httNTQ8K2 aggregates
collected at the times indicated. (b) Primary FTIR spectra of K2Q37K and httNTQ15K2
aggregates with different exposures to H2O (“H”) and D2O (“D”). The first letter indicates
the solvent used for aggregate growth, and the second letter denotes the solvent used for
measurement.
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Model for httNTQN aggregation. Disordered monomeric htt N-terminal fragments (a) (httNT,
green; polyQ, orange or red) spontaneously and reversibly assemble (b) into oligomeric
intermediates in which portions of httNT assemble into a bundled α-helical core (c–e), and
these assemblies grow larger upon incubation. Oligomer formation results in a high local
concentration of polyQ segments, increasing the frequency of formation (f) of nuclei with
segments of polyQ in β-sheet structure (g). Elongation of nuclei (h) and fibrils (i) by
monomer addition generates growing amyloid-like aggregates (j). As fibrils grow and
monomer is depleted, oligomers that have not undergone a productive nucleation reaction
dissociate (b) to provide additional monomers to support fibril elongation. According to the
mechanism in this schematic, nucleation driven by enhanced local polyQ concentrations
might occur within oligomers of any size. The four-helix assemblies serving as the basic
units of oligomer formation in this model are depicted as being antiparallel structures, but
there is no direct evidence for this.
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Table 1





httNTQ4K2 MATLEKLMKA FESLKSWQQQ QKK
httNTQ5K2 MATLEKLMKA FESLKSWQQQ QQKK
httNTQ6K2 MATLEKLMKA FESLKSWQQQ QQQKK
httNTQ7K2 MATLEKLMKA FESLKSWQQQ QQQQKK
httNTQ8K2 MATLEKLMKA FESLKSWQQQ QQQQQKK
httNTQ9K2 MATLEKLMKA FESLKSWQQQ QQQQQQKK
httNTQ10K2 MATLEKLMKA FESLKSFQQQ QQQQQQQKK
httNTQ15K2 MATLEKLMKA FESLKSWQQQ QQQQQQQQQQ QQKK
httNTQ25K2 MATLEKLMKA FESLKSWQQQ QQQQQQQQQQ QQQQQQQQQQ QQKK
httNTQ35K2 MATLEKLMKA FESLKSWQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQKK
httNTQ37 P10K2 MATLEKLMKA FESLKSWQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQPPPPPP PPPPKK
K2Q37K2 KKQQQQQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQQK K
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Table 2
Major FTIR amide I bands of isolated httNTQN final aggregates







httNTQ8K2 1606.6 1627.8 1656.7
httNTQ9K2 1606.3 1627.5 1658.4
httNTQ10K2 1606.6 1630.0 1658.9
httNTQ15K2 1606.8 1627.8 1658.7
httNTQ25K2 1604.3 1625.5 1656.3
httNTQ35K2 1605.0 1625.9 1659.0
httNTQ37P10K2 1605.2 1626.4 1658.9
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Table 3
Seeded elongation rate constants for httNTQ37P10 monomers
Seed aggregate
httNTQ3 httNTQ10 httNTQ15 httNTQ25 No seed
Rate constant (h−1)a 0.085 0.249 0.236 0.316 0.171
a
Pseudo-first-order rate constants from reactions seeded with 7.5 wt% of aggregates.
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